ROYAL BANK OF CANADA

Bank

Position in CRVS — Corvus Pharmaceuticals, Inc.

CIK 1000275 TORONTO, A6

Position in CRVS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$128,378

+$127,224 QoQ

Shares Held

8,593

+10777.2% QoQ

Ownership

0.010%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#136

of 172 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,116,200,383 across 427 Biotechnology names. CRVS ranks #126 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IONS	Ionis Pharmaceuticals Inc	6,182,479	$490,208,754
2	VRTX	Vertex Pharmaceuticals Inc / Ma	980,259	$486,924,048
3	ALNY	Alnylam Pharmaceuticals, Inc.	875,859	$263,659,830
4	INCY	Incyte Corp	1,132,050	$128,329,182
5	REGN	Regeneron Pharmaceuticals, Inc.	174,515	$108,817,078
6	MRNA	Moderna, Inc.	944,457	$66,140,319
7	INSM	INSMED Inc	416,487	$44,405,840
8	HALO	Halozyme Therapeutics, Inc.	545,761	$42,716,712

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$128,378	8,593	+10777.2%	Shares	Defined	2026-08-14
2026-03-31	$1,154	79	-95.1%	Shares	Defined	2026-05-15
2025-12-31	$12,488	1,622	-97.3%	Shares	Defined	2026-02-17
2025-09-30	$448,412	60,843	-47.1%	Shares	Defined	2025-11-14
2025-06-30	$459,816	114,954	+2215.8%	Shares	Defined	2025-11-21
2024-12-31	$26,557	4,964	-31.4%	Shares	Defined	2025-02-14
2024-06-30	$13,173	7,238	+5832.8%	Shares	Defined	2024-11-06
2023-12-31	$214	122	-55.1%	Shares	Defined	2024-02-14
2022-09-30	$222	272	-90.9%	Shares	Defined	2022-11-14
2021-06-30	$8,010	3,000	+200.0%	Shares	Defined	2021-08-16
2021-03-31	$3,080	1,000	+371.7%	Shares	Defined	2021-07-20
2020-09-30	$850	212	+0.5%	Shares	Defined	2020-11-16
2020-06-30	$573	211	+0.5%	Shares	Defined	2020-08-14
2020-03-31	$443	210	—	Shares	Defined	2020-06-16
No filing history on record for this holder in this stock.